Acelyrin Newsroom

ACELYRIN Is Maintained at Overweight by Wells Fargo

Dow JonesOct 16 23:52

Acelyrin Analyst Ratings

BenzingaOct 16 23:44

Wells Fargo Maintains Acelyrin(SLRN.US) With Buy Rating, Raises Target Price to $15

Futu NewsOct 16 18:31

Piper Sandler Maintains Acelyrin(SLRN.US) With Buy Rating, Maintains Target Price $20

Futu NewsSep 25 19:31

ACELYRIN, INC. (SLRN) Receives a Buy From Piper Sandler

TipRanksSep 25 19:29

Morgan Stanley Maintains Acelyrin(SLRN.US) With Hold Rating, Maintains Target Price $6

Futu NewsAug 20 20:33

Acelyrin Analyst Ratings

BenzingaAug 20 01:00

Morgan Stanley Maintains Equal-Weight on Acelyrin, Lowers Price Target to $6

BenzingaAug 20 01:00

Morgan Stanley Maintains Acelyrin(SLRN.US) With Hold Rating, Cuts Target Price to $6

Futu NewsAug 19 21:31

ACELYRIN, INC.: Hold Rating Maintained Amid Strategic Pipeline Shift and Extended Cash Runway

TipRanksAug 19 20:47

HC Wainwright & Co. Downgrades Acelyrin to Neutral, Lowers Price Target to $6

BenzingaAug 16 01:22

A Quick Look at Today's Ratings for Acelyrin(SLRN.US), With a Forecast Between $6 to $20

Futu NewsAug 15 21:01

Acelyrin Analyst Ratings

BenzingaAug 15 00:08

Piper Sandler Maintains Overweight on Acelyrin, Lowers Price Target to $20

BenzingaAug 15 00:07

A Quick Look at Today's Ratings for Acelyrin(SLRN.US), With a Forecast Between $6 to $20

Futu NewsAug 14 21:00

Piper Sandler Keeps Their Buy Rating on ACELYRIN, INC. (SLRN)

TipRanksAug 14 19:16

ACELYRIN, INC. Maintains Hold Rating Amidst Mixed Clinical Results and Competitive Market Challenges

TipRanksAug 14 18:37

Buy Rating Affirmed: Strategic Focus and Promising Pipeline of ACELYRIN, INC.

TipRanksAug 14 10:21

Acelyrin Analyst Ratings

BenzingaJul 8 21:40

Wells Fargo Upgrades ACELYRIN to Overweight From Equalweight, Price Target at $13

MT NewswiresJul 8 18:55